Boryeong Building
136 Changgyeonggung- ro Jongno-gu
Seoul 03127
South Korea
82 2 708 8000
https://www.boryung.co.kr
版塊: Healthcare
行業: Drug Manufacturers - Specialty & Generic
全職員工:
名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
---|---|---|---|---|
Mr. Jay Kim | Chairman & CEO | 無 | 無 | 無 |
Young-Ha Kim | Senior Managing Director, Director of Marketing Division and Director | 無 | 無 | 1954 |
Ho-Young Baek | Director of Operation Support Division and Director | 無 | 無 | 1962 |
Daniel Chang | Chief Executive Officer of Pharma Biz | 無 | 無 | 無 |
Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, diabetes, central nervous system, and oncology drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.
截至 無 止,Boryung Corporation 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。